MechA versus MoA in MSC-sEV therapeutics: bridging realities and expectations
- 14 January 2026
- journal article
- Published by Elsevier in Cytotherapy
- Vol. 28 (4) , 102061
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Overcoming challenges in MSC-sEV therapeutics: insights and advances after a decade of researchCytotherapy, 2025
- Cost and availability of novel cell and gene therapiesEMBO Reports, 2023
- CD73 activity of mesenchymal stromal cell-derived extracellular vesicle preparations is detergent-resistant and does not correlate with immunomodulatory capabilitiesCytotherapy, 2022